CS214721B2 - Method of making the pentahydrate of +l6r,7r+p-7-+l+lz+p-2-+l2-aminothiazol-4-yl+p-2-+l2-carboxyprop-2-oxyimino+p acetamido+p-3-+l1-piridiniummethyl+pcef-3-em-4-carboxylate - Google Patents

Method of making the pentahydrate of +l6r,7r+p-7-+l+lz+p-2-+l2-aminothiazol-4-yl+p-2-+l2-carboxyprop-2-oxyimino+p acetamido+p-3-+l1-piridiniummethyl+pcef-3-em-4-carboxylate Download PDF

Info

Publication number
CS214721B2
CS214721B2 CS806627A CS662780A CS214721B2 CS 214721 B2 CS214721 B2 CS 214721B2 CS 806627 A CS806627 A CS 806627A CS 662780 A CS662780 A CS 662780A CS 214721 B2 CS214721 B2 CS 214721B2
Authority
CS
Czechoslovakia
Prior art keywords
carboxylate
cef
solution
pentahydrate
carboxyprop
Prior art date
Application number
CS806627A
Other languages
Czech (cs)
English (en)
Inventor
Alastair C Brodie
Lewis A Wetherill
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CS214721B2 publication Critical patent/CS214721B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS806627A 1979-10-02 1980-10-01 Method of making the pentahydrate of +l6r,7r+p-7-+l+lz+p-2-+l2-aminothiazol-4-yl+p-2-+l2-carboxyprop-2-oxyimino+p acetamido+p-3-+l1-piridiniummethyl+pcef-3-em-4-carboxylate CS214721B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7934204 1979-10-02

Publications (1)

Publication Number Publication Date
CS214721B2 true CS214721B2 (en) 1982-05-28

Family

ID=10508246

Family Applications (1)

Application Number Title Priority Date Filing Date
CS806627A CS214721B2 (en) 1979-10-02 1980-10-01 Method of making the pentahydrate of +l6r,7r+p-7-+l+lz+p-2-+l2-aminothiazol-4-yl+p-2-+l2-carboxyprop-2-oxyimino+p acetamido+p-3-+l1-piridiniummethyl+pcef-3-em-4-carboxylate

Country Status (36)

Country Link
US (1) US4329453A (fr)
JP (1) JPS5657791A (fr)
KR (1) KR840001776B1 (fr)
AT (1) AT368161B (fr)
AU (1) AU539519B2 (fr)
BE (1) BE885489A (fr)
BG (1) BG33586A3 (fr)
CA (1) CA1142919A (fr)
CH (1) CH645118A5 (fr)
CS (1) CS214721B2 (fr)
CY (1) CY1338A (fr)
DD (1) DD153376A5 (fr)
DE (1) DE3037102C2 (fr)
DK (1) DK155525C (fr)
EC (1) ECSP941099A (fr)
ES (1) ES8106908A1 (fr)
FI (1) FI71157C (fr)
FR (1) FR2466467A1 (fr)
GB (1) GB2063871B (fr)
GR (1) GR69123B (fr)
HK (1) HK78686A (fr)
HU (1) HU184835B (fr)
IT (1) IT1144006B (fr)
KE (1) KE3641A (fr)
MX (1) MX6545E (fr)
MY (1) MY8500315A (fr)
NL (1) NL190329C (fr)
NO (1) NO156246C (fr)
PL (1) PL126606B1 (fr)
PT (1) PT71860B (fr)
RO (1) RO82721B (fr)
SE (1) SE449614B (fr)
SU (1) SU942599A3 (fr)
UA (1) UA7208A1 (fr)
YU (1) YU42357B (fr)
ZA (1) ZA806081B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4427677A (en) 1980-12-31 1984-01-24 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4394503A (en) 1981-12-07 1983-07-19 Bristol-Myers Company Cephalosporin derivatives
US4474954A (en) * 1981-12-07 1984-10-02 Bristol-Myers Company Intermediates for cephalosporin derivatives
JPS58198489A (ja) * 1982-05-14 1983-11-18 Meiji Seika Kaisha Ltd ７β−（２Ｄ−２−アミノ−２−カルボキシエチルチオアセトアミド）−７α−メトキシ−３−（１−メチル−１Ｈ−テトラゾ−ル−５−イル）−チオメチル−３−セフエム−４−カルボン酸ナトリウム塩の七水和物及びその製造方法
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4537959A (en) * 1984-03-26 1985-08-27 Eli Lilly And Company Crystalline cephalosporin antibiotic salt
JPS60231683A (ja) * 1984-05-02 1985-11-18 Teijin Ltd セフアロスポリン誘導体その製造法及びそれを有効成分とする抗菌剤
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
DE3577656D1 (de) * 1984-07-23 1990-06-21 Lilly Co Eli Pharmazeutische zusammensetzungen von ceftazidim.
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
US4659813A (en) * 1984-11-08 1987-04-21 Eli Lilly And Company Crystallization process for ceftazidime derivative
DE3581619D1 (de) * 1984-11-08 1991-03-07 Lilly Co Eli Verfahren zur herstellung von kristallinischem ceftazidime-pentahydrat.
US4994451A (en) * 1988-01-19 1991-02-19 Bristol-Myers Company Cephalosporin salts and injectable compositions
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
AT387390B (de) * 1986-10-07 1989-01-10 Biochemie Gmbh Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
ES2032543T3 (es) * 1987-02-02 1993-02-16 Eli Lilly And Company Procedimiento mejorado de preparacion de un antibiotico.
EP0321562B1 (fr) * 1987-06-25 1993-11-24 Banyu Pharmaceutical Co., Ltd. Composes cristallins de cephalosporine, procede de preparation et produits intermediaires pour la preparation de ces composes
WO1988010262A1 (fr) * 1987-06-25 1988-12-29 Banyu Pharmaceutical Co., Ltd. Compose cristallin de cephalosporine
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
KR940000112B1 (ko) * 1990-07-05 1994-01-05 주식회사 대웅제약 신규의 3-치환 세펨화합물 및 그의 제조방법
US5831085A (en) * 1997-01-16 1998-11-03 Lupin Laboratories Limited Process for manufacture of cephalosporin such as ceftazidime and intermediate thereof
CN1328281C (zh) * 2004-11-16 2007-07-25 广州白云山制药股份有限公司 头孢他啶的纯化方法
CN102875576A (zh) * 2012-10-31 2013-01-16 苏州致君万庆药业有限公司 一种抗菌素头孢他啶的合成、注射用头孢他啶及其制备方法
CN102924483B (zh) * 2012-10-31 2015-06-17 海南合瑞制药股份有限公司 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物
CN104876949A (zh) * 2015-05-28 2015-09-02 浙江长典医药有限公司 一种小儿用头孢他啶化合物实体及其制剂
CN106420658A (zh) * 2016-09-23 2017-02-22 临沂草之美医药科技有限公司 一种治疗外科手术感染的药物头孢他啶胶囊
CN109111467A (zh) * 2017-06-22 2019-01-01 宁应 一种51/4水头孢他啶化合物及其药物组合物制剂

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato

Also Published As

Publication number Publication date
DE3037102A1 (de) 1981-04-23
UA7208A1 (uk) 1995-06-30
IT8049783A0 (it) 1980-10-01
JPH0128036B2 (fr) 1989-05-31
FI71157C (fi) 1986-11-24
PT71860A (en) 1980-11-01
NO156246C (no) 1987-08-19
FI71157B (fi) 1986-08-14
NO156246B (no) 1987-05-11
FI803126L (fi) 1981-04-03
GR69123B (fr) 1982-05-03
ECSP941099A (es) 1995-01-16
AU6288280A (en) 1981-04-09
MY8500315A (en) 1985-12-31
DK414780A (da) 1981-04-03
BE885489A (fr) 1981-04-01
AU539519B2 (en) 1984-10-04
HK78686A (en) 1986-10-24
JPS5657791A (en) 1981-05-20
ZA806081B (en) 1982-05-26
NO802913L (no) 1981-04-03
PL227019A1 (fr) 1981-06-05
FR2466467B1 (fr) 1984-02-10
RO82721A (fr) 1984-09-29
SU942599A3 (ru) 1982-07-07
DK155525B (da) 1989-04-17
YU249780A (en) 1983-02-28
HU184835B (en) 1984-10-29
US4329453A (en) 1982-05-11
CY1338A (en) 1987-01-16
KE3641A (en) 1986-07-11
FR2466467A1 (fr) 1981-04-10
BG33586A3 (en) 1983-03-15
GB2063871B (en) 1983-06-02
CA1142919A (fr) 1983-03-15
NL190329B (nl) 1993-08-16
PT71860B (en) 1982-04-02
ATA490080A (de) 1982-01-15
PL126606B1 (en) 1983-08-31
NL190329C (nl) 1994-01-17
SE8006861L (sv) 1981-04-03
YU42357B (en) 1988-08-31
NL8005443A (nl) 1981-04-06
DE3037102C2 (de) 1986-04-10
SE449614B (sv) 1987-05-11
RO82721B (ro) 1984-10-30
KR830004317A (ko) 1983-07-09
GB2063871A (en) 1981-06-10
AT368161B (de) 1982-09-27
ES495534A0 (es) 1981-09-01
ES8106908A1 (es) 1981-09-01
IT1144006B (it) 1986-10-29
DD153376A5 (de) 1982-01-06
DK155525C (da) 1989-09-04
KR840001776B1 (ko) 1984-10-19
MX6545E (es) 1985-07-10
CH645118A5 (de) 1984-09-14

Similar Documents

Publication Publication Date Title
CS214721B2 (en) Method of making the pentahydrate of +l6r,7r+p-7-+l+lz+p-2-+l2-aminothiazol-4-yl+p-2-+l2-carboxyprop-2-oxyimino+p acetamido+p-3-+l1-piridiniummethyl+pcef-3-em-4-carboxylate
KR0180798B1 (ko) 결정성 페니실린 유도체, 그의 제법 및 용도
KR940005636A (ko) 트리아졸릴티오메틸티오 세팔로스포린 염산염, 그의 수화물 결정 및 이들의 제조방법
US4467086A (en) Cephalosporin antibiotic
US5104866A (en) Water-soluble antibiotic composition and water-soluble salts of cephem compounds
CA1339418C (fr) Antiobiotiques a base de cephalosporine
DE2739448A1 (de) 7-substituierte aminoacetamido- oxadethiacephalosporine, verfahren zu deren herstellung und deren verwendung bei der behandlung bakterieller erkrankungen
JPH01261392A (ja) アシル誘導体及びその製造方法
US4791196A (en) Crystalline cephem carboxylic acid addition salt
US20110118462A1 (en) N-heterocyclic substituent-containing antibiotic, preparation and use thereof
JPH0692970A (ja) トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法
JPH01199977A (ja) セファロスポリン誘導体の結晶、その製造法およびそれらを有効成分とする医薬組成物
JPH04338392A (ja) 新規セフェム誘導体及びその製造方法
RU2029549C1 (ru) Антибиотическая композиция
AT393452B (de) Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
NZ205961A (en) Isomerically enriched alpha-carboxy-3-thienylmethyl penicillin and pharmaceutical compositions